Two Sigma Investments
INBS icon

Two Sigma Investments’s Intelligent Bio Solutions INBS Stock Holding History

Two Sigma Investments’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-284
Closed -$11.5K – 3185
2023
Q4 		$11.5K Buy
+284
New +$11.2K ﹤0.01% 3078

Other funds holding INBS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Investments's INBS Position: Q1 2024 in Review

Two Sigma Investments sold out of Intelligent Bio Solutions (INBS) in Q1 2024, closing a stake of 284 shares — an estimated $11.5K sold.

Two Sigma Investments first reported a position in INBS in Q4 2023 and held it in 1 quarter. The position peaked at $11.5K in Q4 2023. 13 funds tracked by Wall St. Rank hold INBS as of Q1 2024.

  • Two Sigma Investments reported no remaining Intelligent Bio Solutions position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 284 Intelligent Bio Solutions shares in Q1 2024, an estimated $11.5K.
  • Two Sigma Investments first reported a position in Intelligent Bio Solutions in Q4 2023 and held it in 1 quarter.
  • Two Sigma Investments's Intelligent Bio Solutions position peaked at $11.5K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.